E

Sunshine Biopharma, Inc. SBFM

$0.67 -$0.02-3.07% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Sunshine Biopharma, Inc. is a pharmaceutical and healthcare company focused on the development and commercialization of oncology and antiviral therapeutics, as well as the distribution of generic pharmaceuticals. The company operates primarily in the biotechnology and pharmaceutical industries through a combination of drug development activities and commercial pharmaceutical distribution operations. Its revenue base has increasingly been driven by its generic pharmaceutical distribution business, while its biotechnology pipeline remains focused on proprietary drug candidates targeting cancer and viral diseases.

The company evolved from an early-stage biotechnology enterprise into a broader pharmaceutical platform through strategic expansion into generic drug distribution. Sunshine Biopharma has highlighted proprietary research programs involving anticancer compound development and antiviral platform technologies, while also pursuing commercial scale through acquisitions and operational expansion. Its positioning combines higher-risk biotechnology research activities with cash-flow-oriented pharmaceutical distribution operations intended to diversify revenue sources and operational exposure.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)

Price History

Loading...
52-Week Range0% of range
Low
$0.67
Current
$0.67
High
$24.30
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
954 330 0684
Address
333 Las Olas Way
CU4 Suite 433
Fort Lauderdale, FL 33301
Country
Year Founded
--

Headlines